rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2008-3-11
|
pubmed:abstractText |
Idiopathic nephrotic syndrome in children is commonly associated with minimal change disease and response to steroid therapy. Steroid-unresponsive nephrotic syndrome is often characterized by persistent proteinuria and progression to chronic kidney disease. Focal segmental glomerulosclerosis is the leading cause of steroid-unresponsive nephrotic syndrome in childhood. There is no uniformed consensus as to the treatment of steroid-unresponsive nephrotic syndrome. Advances in the pathogenesis, genetics and biomarkers or surrogate markers may be useful for the diagnosis and identification of patients with steroid-unresponsive nephrotic syndrome, severity of disease, progression and response to therapy.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1040-8703
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
151-6
|
pubmed:meshHeading |
pubmed-meshheading:18332710-Child,
pubmed-meshheading:18332710-Cyclosporins,
pubmed-meshheading:18332710-Glomerulosclerosis, Focal Segmental,
pubmed-meshheading:18332710-Humans,
pubmed-meshheading:18332710-Immunosuppressive Agents,
pubmed-meshheading:18332710-Mycophenolic Acid,
pubmed-meshheading:18332710-Nephrotic Syndrome,
pubmed-meshheading:18332710-Randomized Controlled Trials as Topic,
pubmed-meshheading:18332710-Sirolimus,
pubmed-meshheading:18332710-Tacrolimus,
pubmed-meshheading:18332710-Treatment Outcome
|
pubmed:year |
2008
|
pubmed:articleTitle |
Evaluation and management of steroid-unresponsive nephrotic syndrome.
|
pubmed:affiliation |
Division of Pediatric Nephrology, Children's Hospital at Montefiore, Bronx, New York 10467, USA. mdelrio@montefiore.org
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, N.I.H., Extramural
|